Royalty Pharma plc (RPRX) Presents at UBS International Biopharma Convention 2026 Transcript


Royalty Pharma plc (RPRX) UBS International Biopharma Convention 2026 November 17, 2026 5:40 AM EST

Firm Individuals

Christopher Hite – Chairman of Partnering & Investments
Greg Butz – Government Vice President of Partnering & Investments

Convention Name Individuals

Ashwani Verma – UBS Funding Financial institution, Analysis Division

Presentation

Ashwani Verma
UBS Funding Financial institution, Analysis Division

Good day, all people. Thanks a lot for becoming a member of. Welcome again to the subsequent session at UBS Biopharma Convention in London. So I am actually excited to have Royalty Pharma right here and have Chris Hite, who’s the Chairman of Partnering and Investments; and Greg Butz, who’s EVP of Partnering. So thanks, gents, for becoming a member of us.

Christopher Hite
Chairman of Partnering & Investments

Thanks.

Query-and-Reply Session

Ashwani Verma
UBS Funding Financial institution, Analysis Division

Sure, thanks. Type of a really, very distinctive story and really nicely understood by buyers, by some buyers, I’d say. However all the time good to begin with some degree of background simply in order that persons are conscious. And for those who can simply hit a few highlights on a few of the key takeaways from the third quarter earnings as nicely, we are able to begin there.

Christopher Hite
Chairman of Partnering & Investments

Certain. Nicely, thanks once more for having us. We actually recognize the chance. It is an excellent convention. So to begin with perhaps only a background on Royalty Pharma. The corporate is 30 years outdated. We celebrated our thirtieth anniversary not too long ago, actually created with the concept to purchase present royalty streams from hospitals, foundations, universities approach again when, and we nonetheless do this. The corporate went public in 2020. We’re investment-grade rated. Capital deployment publicly acknowledged targets of $2 billion to $2.5 billion a 12 months.

We nonetheless purchase present royalty streams. And — however we have actually kind of morphed the enterprise and grown the enterprise by co-investing



Source link

Related articles

Bitcoin Worth Might Drop Beneath $60K, Wintermute Warns—Here is Why

Key TakeawaysBitcoin fell 13.7% to about $64K, closing under its 200-week shifting common close to $68K.Wintermute hyperlinks the drop to increased price expectations, weak ETF demand, and $1.7B in liquidations.Reclaiming $68K with renewed...

The FAA Floor Cease Reveals Why Community Transformation Should Be Engineered For Failure

A change at two places reportedly destabilized communications throughout 17 of the US Federal Aviation Administration’s (FAA) 22 en-route management facilities. That is greater than an outage story. It’s a warning about what...

Azule Power’s Higher PAJ undertaking advances as Fugro finishes geophysical survey

(WO) – Fugro has accomplished the survey part of a geophysical program for Azule Power’s Higher PAJ undertaking offshore Angola. The info will help the design of subsea infrastructure and assist optimize subsea...

US October advance retail gross sales +0.2% vs +0.2% anticipated

Prior was +0.8%Ex autos +0.6% vs +0.4% anticipatedPrior ex-autos +0.9% (revised to +1.1%)Retail gross sales management group +0.6% vs +0.4% anticipatedPrior management was +0.1% (revised to +0.5%)Ex autos and gasoline +0.5% vs +0.2%...

Revolut Plans 4 Blockchain Funds For Illiquid Markets

Revolut plans to launch 4 funds utilizing blockchain to supply fractional investments in illiquid markets, chair Martin Gilbert mentioned Tuesday at Solana’s Breakpoint convention in London.Blockchain, he defined, could be used to divide...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com